These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16581323)

  • 1. Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.
    Ito M; Nakayama K; Konaka A; Sakata K; Ikeda K; Maruyama T
    Bone; 2006 Sep; 39(3):453-9. PubMed ID: 16581323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W; Balooch G; Balooch M; Jiang Y; Nalla RK; Kinney J; Wronski TJ; Lane NE
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading.
    Hagino H; Kuraoka M; Kameyama Y; Okano T; Teshima R
    Bone; 2005 Mar; 36(3):444-53. PubMed ID: 15777678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia.
    Ito M; Nishida A; Aoyagi K; Uetani M; Hayashi K; Kawase M
    Osteoporos Int; 2005 Sep; 16(9):1042-8. PubMed ID: 15711780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
    Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
    J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
    Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
    J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regionally specific compensation for bone loss in the tibial trabeculae of estrogen-deficient rats.
    Sheng ZF; Dai RC; Wu XP; Fang LN; Fan HJ; Liao EY
    Acta Radiol; 2007 Jun; 48(5):531-9. PubMed ID: 17520429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
    Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
    Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic effects of glucocorticoid on bone mineral density and microarchitecture: experiment with rats].
    Liu SP; Chen J; Yang SM; Wu XP; Liao EY; Sheng ZF; Mo H; Ma YL; Zhang YH; Liu W; Jin Y; Dai RC
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2281-4. PubMed ID: 19087680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.